Outcomes of Antipsychotic Medication Used in the Emergency Department

Outcomes of Antipsychotic Medication Use in the Emergency Department: A Retrospective Comparison Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02504450

Acronym

OAMED

Enrollment

Registered

2015-07-22

Start date

2015-04-30

Completion date

2016-03-31

Last updated

2024-10-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Agitation,Psychomotor

Keywords

Bipolar 1 disorder, schizophrenia

Brief summary

To review records of patients treated with antipsychotics (including Adasuve, Geodon, Haldol) in order to evaluate outcomes.

Detailed description

A retrospective chart review will be performed for all patients presenting to the ED with agitation and subsequently given antipsychotic therapy for treatment. Identification of patients will be through chart review of patients presenting with agitation. Data to be recorded include patient age, gender, medical history, time of presentation, time of treatment, co morbidities, use of restraint, time to disposition and patient outcome. Inclusion criteria include all patients over age 18 presenting to the ED with agitation and treated with antipsychotics. No patients will be knowingly excluded from analysis. We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.

Interventions

DRUGAdasuve

Inhaled medication to treat acute agitation in the emergency department

DRUGAlternative medications

Medication given to treat acute agitation in the emergency department

Study design

Observational model

CASE_ONLY

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* All patients given antipsychotic therapy for acute agitation

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame	Description
Length of stay in the emergency department	Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.	We will compare resulting outcomes of patients treated for agitation to see if Adasuve is superior to other commonly prescribed antipsychotics through its rate of discharge home and overall time in the emergency department.

Secondary

Measure	Time frame	Description
Disposition	Participants will be followed for the duration of emergency department stay, an expected average of 12 hours.	disposition (home, transfer, admit), and time to disposition

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026